These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19016501)

  • 21. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biocompatibility and drug release behavior of spontaneously formed phospholipid polymer hydrogels.
    Kimura M; Takai M; Ishihara K
    J Biomed Mater Res A; 2007 Jan; 80(1):45-54. PubMed ID: 16958047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells.
    Na K; Lee ES; Bae YH
    Bioconjug Chem; 2007; 18(5):1568-74. PubMed ID: 17688320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjugated Polymer Nanoparticles Based on Copper Coordination for Real-Time Monitoring of pH-Responsive Drug Delivery.
    Li J; Du N; Tan Y; Hsu HY; Tan C; Jiang Y
    ACS Appl Bio Mater; 2021 Mar; 4(3):2583-2590. PubMed ID: 35014375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
    Etrych T; Jelínková M; Ríhová B; Ulbrich K
    J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immobilization and intracellular delivery of an anticancer drug using mussel-inspired polydopamine capsules.
    Cui J; Yan Y; Such GK; Liang K; Ochs CJ; Postma A; Caruso F
    Biomacromolecules; 2012 Aug; 13(8):2225-8. PubMed ID: 22792863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable click capsules with engineered drug-loaded multilayers.
    Ochs CJ; Such GK; Yan Y; van Koeverden MP; Caruso F
    ACS Nano; 2010 Mar; 4(3):1653-63. PubMed ID: 20201548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifunctional hollow nanoparticles based on graft-diblock copolymers for doxorubicin delivery.
    Lu PL; Chen YC; Ou TW; Chen HH; Tsai HC; Wen CJ; Lo CL; Wey SP; Lin KJ; Yen TC; Hsiue GH
    Biomaterials; 2011 Mar; 32(8):2213-21. PubMed ID: 21176954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double-stranded RNA homopolymer poly(rC).poly(rG) for a new pH-sensitive drug carrier.
    Asayama S; Ogawa A; Kawakami H; Nagaoka S
    Mol Pharm; 2008; 5(1):162-4. PubMed ID: 18161943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric anticancer drugs with pH-controlled activation.
    Ulbrich K; Etrych T; Chytil P; Pechar M; Jelinkova M; Rihova B
    Int J Pharm; 2004 Jun; 277(1-2):63-72. PubMed ID: 15158969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.
    Munnier E; Cohen-Jonathan S; Linassier C; Douziech-Eyrolles L; Marchais H; Soucé M; Hervé K; Dubois P; Chourpa I
    Int J Pharm; 2008 Nov; 363(1-2):170-6. PubMed ID: 18687392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
    Dong DW; Tong SW; Qi XR
    J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system.
    Wong HL; Bendayan R; Rauth AM; Xue HY; Babakhanian K; Wu XY
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1372-81. PubMed ID: 16547167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Controlled release of doxorubicin from thermosensitive poly(organophosphazene) hydrogels.
    Kang GD; Cheon SH; Song SC
    Int J Pharm; 2006 Aug; 319(1-2):29-36. PubMed ID: 16677786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endosomal pH-activatable poly(ethylene oxide)-graft-doxorubicin prodrugs: synthesis, drug release, and biodistribution in tumor-bearing mice.
    Zhou L; Cheng R; Tao H; Ma S; Guo W; Meng F; Liu H; Liu Z; Zhong Z
    Biomacromolecules; 2011 May; 12(5):1460-7. PubMed ID: 21332185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norbornene derived doxorubicin copolymers as drug carriers with pH responsive hydrazone linker.
    Rao N V; Mane SR; Kishore A; Das Sarma J; Shunmugam R
    Biomacromolecules; 2012 Jan; 13(1):221-30. PubMed ID: 22107051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Ríhová B; Ulbrich K
    J Control Release; 2006 Sep; 115(1):26-36. PubMed ID: 16899320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel tetrapeptide, RGDF, mediated tumor specific liposomal doxorubicin (DOX) preparations.
    Du H; Cui C; Wang L; Liu H; Cui G
    Mol Pharm; 2011 Aug; 8(4):1224-32. PubMed ID: 21630705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.